BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11069998)

  • 1. The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.
    Bacharach E; Gonsky J; Alin K; Orlova M; Goff SP
    J Virol; 2000 Dec; 74(23):11027-39. PubMed ID: 11069998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
    Ueno T; Tokunaga K; Sawa H; Maeda M; Chiba J; Kojima A; Hasegawa H; Shoya Y; Sata T; Kurata T; Takahashi H
    Microbiol Immunol; 2004; 48(2):111-8. PubMed ID: 14978336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production.
    Wang MQ; Kim W; Gao G; Torrey TA; Morse HC; De Camilli P; Goff SP
    J Biol; 2003; 3(1):4. PubMed ID: 14659004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.
    Yovandich JL; Chertova EN; Kane BP; Gagliardi TD; Bess JW; Sowder RC; Henderson LE; Gorelick RJ
    J Virol; 2001 Jan; 75(1):115-24. PubMed ID: 11119580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.
    Wang MQ; Goff SP
    J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of retroviral late domains as determinants of particle size.
    Garnier L; Parent LJ; Rovinski B; Cao SX; Wills JW
    J Virol; 1999 Mar; 73(3):2309-20. PubMed ID: 9971814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
    Cimarelli A; Sandin S; Höglund S; Luban J
    J Virol; 2000 Apr; 74(7):3046-57. PubMed ID: 10708419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
    Cimarelli A; Luban J
    J Virol; 2000 Aug; 74(15):6734-40. PubMed ID: 10888611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly.
    Olson ED; Musier-Forsyth K
    Semin Cell Dev Biol; 2019 Feb; 86():129-139. PubMed ID: 29580971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
    Burniston MT; Cimarelli A; Colgan J; Curtis SP; Luban J
    J Virol; 1999 Oct; 73(10):8527-40. PubMed ID: 10482606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional reconstitution of lost activity of chemically cross-linked or mutant moloney murine leukemia virus nucleocapsid proteins by trans-complementation.
    Heldsinger A; Sharmeen L
    Arch Virol; 2001 Dec; 146(12):2385-400. PubMed ID: 11811687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes.
    Muriaux D; Mirro J; Nagashima K; Harvin D; Rein A
    J Virol; 2002 Nov; 76(22):11405-13. PubMed ID: 12388701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.
    Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E
    J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity.
    Housset V; Darlix JL
    C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.